Lumenis

Executive Summary

Lumenis is a global leader in minimally-invasive clinical solutions for aesthetic and ophthalmology markets, renowned for its energy-based technologies including CO2, Intense Pulsed Light (IPL), and Radio-Frequency (RF) devices. Founded in 1991 and headquartered in Munich, Germany, the company has a strong track record of innovation and commercial success across dermatology and ophthalmic applications. With a comprehensive portfolio of proprietary devices, Lumenis addresses high-demand procedures such as skin rejuvenation, hair removal, and vision correction, serving both medical professionals and patients worldwide. The company's deep expertise in energy-based modalities positions it well to capture growth in non-invasive aesthetic treatments and advanced ophthalmology solutions, especially as demand for minimally-invasive procedures continues to rise globally.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation IPL platform for aesthetic dermatology70% success
• Q2 2027FDA clearance for novel ophthalmology laser system60% success
• Q3 2026Strategic distribution partnership in Asia-Pacific markets75% success